Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002525646 | SCV000554623 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620432 | SCV000738078 | likely benign | Cardiovascular phenotype | 2017-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001190662 | SCV001358216 | benign | Cardiomyopathy | 2018-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001595009 | SCV001829628 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265772 | SCV002548114 | benign | not specified | 2022-05-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506139 | SCV002807504 | likely benign | Arrhythmogenic right ventricular dysplasia 2; Catecholaminergic polymorphic ventricular tachycardia 1; Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | 2021-08-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002021 | SCV004822150 | benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-01-11 | criteria provided, single submitter | clinical testing |